Jaimie Brown is set to take the role of director in the agency's health and wellbeing practice in the UK. He joins from his current role as associate director at Ruder Finn's healthcare division.
Brown's role will be to strengthen the existing senior team in the healthcare group, reporting to healthcare and wellbeing MD Fiona Rollo.
His initial focus will be to add senior support to global clients including pharma firms Merck, Amgen and Organon. He will also implement a 'healthcare diversification' strategy, working with chairman of corporate and healthcare Stuart Smith.
Brown has spent 14 years in pharmaceutical sales and marketing. Before his current role at Ruder Finn he worked at pharma firm Pfizer in New York, Europe and the UK. He left his role as a business unit director in 2007.
H&K's healthcare team has gone through a period of change since joint MD Shipra Singh left in January (PRWeek, 31 January).
At the time H&K CEO Sally Costerton confirmed the agency had engaged headhunters to replace Singh and to look for other senior communicators to expand the team.
Singh has since resurfaced at Bell Pottinger Group (PRWeek, 21 March). Bell Pottinger is revamping its healthcare offering and has stated its intent to buy agencies.
The newly created Bell Pottinger Health brand incorporates existing healthcare agency De Facto and newly acquired MC Bio-Communications.